The hypodermic syringes market is expected to continue its stronghold as the market flourishes at an average CAGR of 3.2%. In contrast, the market is valued at US$ 3.51 Bn in 2022 and is projected to reach market revenue of US$ 4.66 Bn through 2032.
The market is anticipated to show promising growth prospects during the forecast period, expanding the hypodermic syringes market size.
Attributes | Details |
---|---|
CAGR (2022 to 2032) | 3.2% |
Value (2022) | US$ 3.51 Billion |
Value (2032) | US$ 4.66 Billion |
The term hypodermic explains its application in “hypo,” which stands for beneath. In contrast, “derm” stands for skin, explaining hypodermic syringes to be used in withdrawing the fluid from the body or injecting fluid into the body. As these chronic diseases keep rising, the use of these syringes has been booming. The easing factor also fuels the demand for hypodermic syringes in the medical sector.
A research report on the hypodermic syringes market explains that the leading government initiatives and dosing errors associated with syringes have pushed the sales of hypodermic syringes in healthcare markets. Other factors that drive the traction of the hypodermic syringes market are aggressive price ranges and new schemes. This pushes the sales of hypodermic syringes.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global hypodermic syringes market is expected to flourish under the backdrop of the global pharmaceutical industry during the forecast period. Hypodermic syringes are preferred over after-filled syringes as they offer fixed dosages of the drug and ease in usability.
Prefill ability helps in reducing the overall cost by reducing the drug overfill. Single-dose vials or multi-dose vials have a drug overfill of almost 20-25% so that the administrator has enough to fill the correct dose and to compensate for human errors, flourishing the demand for hypodermic syringes.
However, prefilled hypodermic syringes eradicate the source of inefficiency in the manufacturing process by eliminating drug overfills. This is particularly advantageous for companies dealing with costly biopharmaceuticals. The growth of the biologics market is likely to boost the hypodermic syringes market.
The conventional syringes were made of glass barrels and glass rods, which were comparatively expensive to manufacture when compared to plastic-based hypodermic syringes, pushing the sales of hypodermic syringes globally.
Healthcare workers benefit from accurate and pre-measured doses. Demand for hypodermic syringes is also fueled by reduced dosing, medication errors, and decreased microbial contamination risk. Along with this, an increasing trend of people getting vaccinated outside hospitals such as in schools, community centers, pharmacies, and airport booths is likely to contribute to the growth of the hypodermic syringes market.
Geographically, the global hypodermic syringes market has been divided into seven key regions: North America, Latin America, East Asia, South Asia, Europe, the Middle East & Africa (MEA), and Oceania. Europe is expected to hold maximum market share in the global hypodermic syringes market owing to the well-established healthcare industry in the region.
The healthcare sector in India is diversified and offers enormous opportunities in every segment, which includes payers, providers, and medical technology. Increasing competition pushing businesses to explore and adapt according to the latest trends and dynamics is expected to impact the hypodermic syringes market in the country positively.
The key players in the hypodermic syringes market are focusing on mergers and collaborations that are fueling the sales of Hypodermic syringes including Terumo Corporation, Albert David Ltd., Becton, Dickinson and Company, Nipro Corporation, Smiths Medical, Hindustan Syringes & Medical Devices Limited etc.
Recent Market Development:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 3.2% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2021 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in USD Million, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered | Material type, Sales Channel, End-user, Region |
Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
Key companies profiled | Terumo Corporation; Albert David Ltd.; Becton; Dickinson and Company; Nipro Corporation; Smiths Medical; Hindustan Syringes & Medical Devices Limited etc. |
Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The hypodermic syringes market is set to thrive at a CAGR of 3.2% through 2032.
Europe holds the biggest revenue in the hypodermic syringes market, the region’s growth owing to its application in healthcare as it eases out the diagnostic and clinical procedures coupled with the spread of covid-19. This leads to the high demand for hypodermic syringes in developed countries like Spain and France.
Demand for hypodermic syringes market size has expanded owing to their use as sustainable tool for withdrawing the fluids as well as injecting the fluid beneath the human skin.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Material Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Material Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Material Type, 2022-2032 5.3.1. Polymer Syringes 5.3.2. Cyclic Olefin Polymers (COP) 5.3.3. Cyclic Olefin Copolymers (COC) 5.3.4. Polypropylene and Other Polymers 5.3.5. Glass Syringes 5.4. Y-o-Y Growth Trend Analysis By Material Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Material Type, 2022-2032 6. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Sales Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Sales Channel, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Sales Channel, 2022-2032 6.3.1. Manufacturers 6.3.2. Distributors 6.3.3. Retailers 6.4. Y-o-Y Growth Trend Analysis By Sales Channel, 2017-2021 6.5. Absolute $ Opportunity Analysis By Sales Channel, 2022-2032 7. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospital 7.3.2. Diabetic Care Centers 7.3.3. Blood Collection Centers 7.3.4. Veterinary Care Centers 7.3.5. Clinics 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 8. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Material Type 9.2.3. By Sales Channel 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Material Type 9.3.3. By Sales Channel 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Chile 10.2.1.5. Peru 10.2.1.6. Rest of Latin America 10.2.2. By Material Type 10.2.3. By Sales Channel 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Material Type 10.3.3. By Sales Channel 10.3.4. By End User 10.4. Key Takeaways 11. Europe Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Material Type 11.2.3. By Sales Channel 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Material Type 11.3.3. By Sales Channel 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Rest of Asia Pacific 12.2.2. By Material Type 12.2.3. By Sales Channel 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Material Type 12.3.3. By Sales Channel 12.3.4. By End User 12.4. Key Takeaways 13. Middle East and Africa Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Turkey 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Material Type 13.2.3. By Sales Channel 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Material Type 13.3.3. By Sales Channel 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Hypodermic Syringes Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Material Type 14.1.2.2. By Sales Channel 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Material Type 14.2.2.2. By Sales Channel 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Material Type 14.3.2.2. By Sales Channel 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Material Type 14.4.2.2. By Sales Channel 14.4.2.3. By End User 14.5. Argentina 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Material Type 14.5.2.2. By Sales Channel 14.5.2.3. By End User 14.6. Chile 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Material Type 14.6.2.2. By Sales Channel 14.6.2.3. By End User 14.7. Peru 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Material Type 14.7.2.2. By Sales Channel 14.7.2.3. By End User 14.8. Germany 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Material Type 14.8.2.2. By Sales Channel 14.8.2.3. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Material Type 14.9.2.2. By Sales Channel 14.9.2.3. By End User 14.10. France 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Material Type 14.10.2.2. By Sales Channel 14.10.2.3. By End User 14.11. U.K. 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Material Type 14.11.2.2. By Sales Channel 14.11.2.3. By End User 14.12. Spain 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Material Type 14.12.2.2. By Sales Channel 14.12.2.3. By End User 14.13. Russia 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Material Type 14.13.2.2. By Sales Channel 14.13.2.3. By End User 14.14. BENELUX 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Material Type 14.14.2.2. By Sales Channel 14.14.2.3. By End User 14.15. China 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Material Type 14.15.2.2. By Sales Channel 14.15.2.3. By End User 14.16. Japan 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Material Type 14.16.2.2. By Sales Channel 14.16.2.3. By End User 14.17. South Korea 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Material Type 14.17.2.2. By Sales Channel 14.17.2.3. By End User 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Material Type 14.18.2.2. By Sales Channel 14.18.2.3. By End User 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Material Type 14.19.2.2. By Sales Channel 14.19.2.3. By End User 14.20. Turkey 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Material Type 14.20.2.2. By Sales Channel 14.20.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Material Type 15.3.3. By Sales Channel 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Terumo Corporation 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Albert David 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Becton, Dickinson and Company 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Nipro Corporation 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Smiths Medical 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Hindustan Syringes & Medical Devices Limited 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports